Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

593
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
593
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Contribution of Radial Endobronchial Ultrasound (EBUS) in the Diagnosis of Pulmonary Cystic Lesions.

Cureus·2026
Same author

Atypical Adenomatous Hyperplasia as a Precursor of Lung Adenocarcinoma.

Cureus·2025
Same author

Fire-eater's pneumonia: exogenous lipoid pneumonia in a young circus performer.

The American journal of medicine·2025
Same author

Ciliated Muconodular Papillary Tumor: Mimicking Lung Adenocarcinoma.

The American journal of medicine·2025
Same author

Diaphragm dysfunction: how to diagnose and how to treat?

Breathe (Sheffield, England)·2025
Same author

Publisher Correction: Hyperbaric oxygen therapy in the treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.

Scientific reports·2024

Related Experiment Video

Updated: Aug 1, 2025

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

1.8K

NUT carcinoma - An aggressive thoracic tumor.

Joana Arana Ribeiro1, Jéssica Sousa2, Filipa Jesus1

  • 1Pulmonology Department, Unidade Local de Saúde da Guarda, E.P.E., Portugal.

The American Journal of the Medical Sciences
|April 26, 2023
PubMed
Summary

Nuclear protein in the testis (NUT) carcinoma is a rare, undifferentiated cancer often misdiagnosed. Early consideration in differential diagnoses is crucial for timely treatment.

Keywords:
NUT CarcinomaNUTM1 geneNuclear Protein in Testis

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.6K
Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules
06:03

Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules

Published on: May 23, 2015

22.4K

Related Experiment Videos

Last Updated: Aug 1, 2025

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

1.8K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.6K
Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules
06:03

Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules

Published on: May 23, 2015

22.4K

Area of Science:

  • Oncology
  • Genetics

Background:

  • Nuclear protein in testis (NUT) carcinoma is an extremely rare malignancy defined by NUT gene rearrangements.
  • This undifferentiated cancer presents diagnostic and therapeutic challenges due to its rarity.

Observation:

  • NUT carcinoma is often misdiagnosed because of its rarity and the need for specific molecular studies.
  • It typically affects children and young adults, presenting as a rapidly progressive malignancy in the head, neck, or thorax.

Findings:

  • The study reports an unusual case of NUT carcinoma presenting with pleural effusion in an adult patient.
  • This highlights the diverse clinical presentations of NUT carcinoma beyond typical demographics.

Implications:

  • NUT carcinoma should be considered in the differential diagnosis of poorly differentiated or undifferentiated malignancies, especially in young individuals.
  • Increased awareness and molecular testing are vital for accurate diagnosis and improved management of this rare cancer.